A real-world study gives the edge to Eli Lilly’s weight-loss drug, Amazon faces a potential antitrust hurdle in iRobot deal, and other news to start your day.
The Fed Won’t Talk About Rate Cuts. Why Traders Are Betting on Them.
2023-11-28 06:27
A real-world study gives the edge to Eli Lilly’s weight-loss drug, Amazon faces a potential antitrust hurdle in iRobot deal, and other news to start your day.
You Might Like...
Karpowership, Mulilo Have South African Grid-Access Rights Extended
SolarEdge Unveils Commercial Storage System at Intersolar 2023
Apple Photo Stream: iPhone users urged to check their library before photos are permanently deleted
Scientists discover reason why we experience deja vu
UK regulator issues notice to Snapchat over privacy risks posed by AI chatbot
Google Cloud to open office in El Salvador in seven-year partnership
Scientists make 'shocking' discovery that life could be hiding on Saturn's moon
Stocks Poised for Muted Open